Cargando…

Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis

Human schistosomiasis is a neglected tropical disease caused by Schistosoma mansoni, S. haematobium, and S. japonicum. Praziquantel (PZQ) is the method of choice for treatment. Due to constant selection pressure, there is an urgent need for new therapies for schistosomiasis. Previous treatment of S....

Descripción completa

Detalles Bibliográficos
Autores principales:	Alwan, Sevan N., Taylor, Alexander B., Rhodes, Jayce, Tidwell, Michael, McHardy, Stanton F., LoVerde, Philip T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359000/ https://www.ncbi.nlm.nih.gov/pubmed/37428793 http://dx.doi.org/10.1371/journal.ppat.1011018

Ejemplares similares

Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments
por: Toth, Katalin, et al.
Publicado: (2023)

Rational approach to drug discovery for human schistosomiasis
por: LoVerde, Philip T., et al.
Publicado: (2021)

Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]
por: LoVerde, Philip T., et al.
Publicado: (2022)

An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans
por: Guzman, Meghan A., et al.
Publicado: (2020)

Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
por: Rugel, Anastasia R., et al.
Publicado: (2020)

Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine
por: Taylor, Alexander B., et al.
Publicado: (2015)

Schistosome Sulfotransferases: Mode of Action, Expression and Localization
por: Guzman, Meghan A., et al.
Publicado: (2022)

Oxamniquine resistance alleles are widespread in Old World Schistosoma mansoni and predate drug deployment
por: Chevalier, Frédéric D., et al.
Publicado: (2019)

Praziquantel for the treatment of schistosomiasis during human pregnancy
por: Friedman, Jennifer F, et al.
Publicado: (2018)

Anaphylactic reaction to praziquantel following schistosomiasis treatment
por: Vasconcelos, Géssica Almeida, et al.
Publicado: (2023)

Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis
por: Fukuchi, Takahiko, et al.
Publicado: (2019)

Human Schistosomiasis Resistance to Praziquantel in China: Should We Be Worried?
por: Seto, Edmund Y. W., et al.
Publicado: (2011)

Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni
por: HEGAZY, Laila Abdel Moniem, et al.
Publicado: (2018)

Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model
por: Carvalho-Queiroz, Claudia, et al.
Publicado: (2015)

Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
por: Pearson, Mark S., et al.
Publicado: (2021)

Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis Treatment
por: Meyer, Thorsten, et al.
Publicado: (2009)

Performance and Safety of Praziquantel for Treatment of Intestinal Schistosomiasis in Infants and Preschool Children
por: Sousa-Figueiredo, José C., et al.
Publicado: (2012)

Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel
por: Walker, Joseph W., et al.
Publicado: (2020)

Authors' Response to “Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis”
por: Koizumi, Yohei, et al.
Publicado: (2019)

The Role of Praziquantel in the Prevention and Treatment of Fibrosis Associated with Schistosomiasis: A Review
por: Niu, Xuehua, et al.
Publicado: (2022)

Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
por: Holtfreter, Martha C., et al.
Publicado: (2023)

Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis
por: Liu, Rong, et al.
Publicado: (2011)

Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment
por: Miranda, Vitor Hugo Simões, et al.
Publicado: (2020)

Identification and evolution of nuclear receptors in Platyhelminths
por: Wu, Wenjie, et al.
Publicado: (2021)

Updated knowledge and a proposed nomenclature for nuclear receptors with two DNA binding domains (2DBD-NRs)
por: Wu, Wenjie, et al.
Publicado: (2023)

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
por: Bustinduy, Amaya L., et al.
Publicado: (2016)

Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel
por: Yepes, Edward, et al.
Publicado: (2015)

Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment
por: Albertini, Beatrice, et al.
Publicado: (2019)

Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
por: Bergquist, Robert, et al.
Publicado: (2017)

Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
por: Opio, Christopher Kenneth, et al.
Publicado: (2020)

Large CRISPR-Cas-induced deletions in the oxamniquine resistance locus of the human parasite Schistosoma mansoni
por: Sankaranarayanan, Geetha, et al.
Publicado: (2021)

A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
por: Zhou, Yi-biao, et al.
Publicado: (2011)

Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy
por: Silveira-Lemos, Denise, et al.
Publicado: (2013)

Development of the PraziCalc mobile device-app to calculate praziquantel dosage in the treatment of schistosomiasis
por: Viana, Agostinho Gonçalves, et al.
Publicado: (2018)

Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment
por: Melkus, Michael W., et al.
Publicado: (2020)

Parasitological Observation in Schoolchildren with Urogenital Schistosomiasis Following Treatment with Three Different Brands of Praziquantel
por: Jin, Yan, et al.
Publicado: (2020)

Efficacy of a low‐dose praziquantel and fenbendazole protocol in the treatment of asymptomatic schistosomiasis in dogs
por: Cridge, Harry, et al.
Publicado: (2021)

Efficacy of Praziquantel for the Treatment of Human Schistosomiasis in Ethiopia: A Systematic Review and Meta-Analysis
por: Hailegebriel, Tamirat, et al.
Publicado: (2021)

The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models
por: Paulino, Érica Tex, et al.
Publicado: (2022)

The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa
por: Baan, Marije, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t0kg5gu09pd23knd4iujfhvu9o